NVIDIA releases framework for the prediction of protein, molecules, and DNA

World’s leading pharma companies, biotech startups and pioneering researchers are developing AI applications with the NVIDIA BioNeMo LLM service and framework to generate, predict and understand biomolecular data.
Listen to this story

Scientists have been probing for new insights about proteins, DNA, and other building blocks of life. The NVIDIA BioNeMo framework, announced at NVIDIA GTC 2022, is set to accelerate their research. 

NVIDIA BioNeMo is a framework for training and deploying large biomolecular language models

at the supercomputing scale. The large language model (LLM) framework will support chemistry, protein, DNA and RNA data formats, which aims to help scientists better understand disease and find therapies for patients. 

This would be a part of the NVIDIA Clara Discovery applications, collection of frameworks, and AI models for drug discovery. As AI is learning to understand human languages with LLMs, it’s also learning the languages of chemistry and biology. The framework would make it easier to train massive neural networks on biomolecular data and help researchers discover new patterns and insights in biological sequences. With these fresh insights, researchers can connect to biological functions, including human health conditions.

“As we see the ever-widening adoption of large language models in the protein space, being

able to efficiently train LLMs and quickly modulate model architectures is becoming hugely

important,” said Istvan Redl, machine learning lead at Peptone, a biotech startup in the NVIDIA

Inception program. “We believe that these two engineering aspects—scalability and rapid

experimentation—are exactly what the BioNeMo framework could provide.”

The framework will be available in early access on NVIDIA GPU Cloud, a hub for GPU-optimised software. A wave of experts in biotech and pharma such as AstraZeneca, OpenFold, Peptone, and Evozyne, including researchers at the Broad Institute of MIT and Harvard are adopting NVIDIA BioNeMo to support drug discovery research.

Download our Mobile App

Bhuvana Kamath
I am fascinated by technology and AI’s implementation in today’s dynamic world. Being a technophile, I am keen on exploring the ever-evolving trends around applied science and innovation.

Subscribe to our newsletter

Join our editors every weekday evening as they steer you through the most significant news of the day.
Your newsletter subscriptions are subject to AIM Privacy Policy and Terms and Conditions.

Our Upcoming Events

15th June | Online

Building LLM powered applications using LangChain

17th June | Online

Mastering LangChain: A Hands-on Workshop for Building Generative AI Applications

Jun 23, 2023 | Bangalore

MachineCon 2023 India

26th June | Online

Accelerating inference for every workload with TensorRT

MachineCon 2023 USA

Jul 21, 2023 | New York

Cypher 2023

Oct 11-13, 2023 | Bangalore

3 Ways to Join our Community

Telegram group

Discover special offers, top stories, upcoming events, and more.

Discord Server

Stay Connected with a larger ecosystem of data science and ML Professionals

Subscribe to our Daily newsletter

Get our daily awesome stories & videos in your inbox